“Nail Outcome Improvements With Certolizumab Pegol in Moderate to Severe Plaque Psoriasis: Results from Phase 3 Trials”. 2019. SKIN The Journal of Cutaneous Medicine 3 (November): S38. https://doi.org/10.25251/skin.3.supp.38.